<br />
DERMATOLOGY<br />
Reprints • emjreviews.com<br />
EADV ANNUAL CONGRESS 2016<br />
AUSTRIA CENTER VIENNA, VIENNA, AUSTRIA<br />
28TH SEPTEMBER-2ND OCTOBER 2016<br />
Useful Photoprotection in Dermatological Practice<br />
USEFUL PHOTOPROTECTION IN<br />
DERMATOLOGICAL PRACTICE<br />
This symposium took place on 30th September 2016<br />
as a part of the European Academy of Dermatology and<br />
Venereology (EADV) Congress 2016 in Vienna, Austria<br />
Chairperson<br />
Franz Trautinger1<br />
Speakers<br />
Thierry Passeron,2 Dominique Moyal3<br />
1. Karl Landsteiner Institute of Dermatological Research, St. Pölten, Austria<br />
2. Department of Dermatology, University Hospital of Nice, Nice, France<br />
3. La Roche-Posay Dermatological Laboratories, Asnières, France<br />
Disclosure: Prof Trautinger has acted as consultant/advisor to AbbVie, Angelini, BMS, Eli Lilly, Galderma,<br />
Leo, MSD, Novartis, Roche, and Sanofi; received speaker’s h<a title="EMJ Dermatology 2016 ePrint page 1" href="http://viewer.zmags.com/publication/d179f3fc?page=1"> DERMATOLOGY Reprints • emjreviews.com EADV ANNUAL</a>
<a title="EMJ Dermatology 2016 ePrint page 2" href="http://viewer.zmags.com/publication/d179f3fc?page=2"> USEFUL PHOTOPROTECTION IN DERMATOLOGICAL PRACTIC</a>
<a title="EMJ Dermatology 2016 ePrint page 3" href="http://viewer.zmags.com/publication/d179f3fc?page=3"> Photoprotection Needs for Patients with Hyperpigm</a>
<a title="EMJ Dermatology 2016 ePrint page 4" href="http://viewer.zmags.com/publication/d179f3fc?page=4"> Table 1: Pigmentation protection factor determina</a>
<a title="EMJ Dermatology 2016 ePrint page 5" href="http://viewer.zmags.com/publication/d179f3fc?page=5"> cases (2.7%) of melasma were observed, compared t</a>
<a title="EMJ Dermatology 2016 ePrint page 6" href="http://viewer.zmags.com/publication/d179f3fc?page=6"> sebum production, and infection and colonisation </a>
<a title="EMJ Dermatology 2016 ePrint page 7" href="http://viewer.zmags.com/publication/d179f3fc?page=7"> Systemic tetracyclines, most commonly doxycycline</a>
<a title="EMJ Dermatology 2016 ePrint page 8" href="http://viewer.zmags.com/publication/d179f3fc?page=8"> had no or almost no lesions, 21% had low-level ac</a>